This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Other. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Paul Borron: Innovator in Antigenic Response Technologies
Introduction
Paul Borron is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of immunology through his innovative research and patenting efforts. His work focuses on enhancing antigenic responses, which is crucial for improving cancer treatment and immune system functionality.
Latest Patents
Paul Borron holds a patent titled "Methods and compositions for producing antigenic responses." This invention relates to methods of producing an antigenic response by contacting an antigen with an antigen-presenting cell. The improvement involves using an adenosine receptor activating agent to enhance the antigenic response of the antigen-presenting cell. This patent also encompasses various methods, compositions, combination therapies, imaging techniques, and diagnostic kits aimed at improving the diagnosis, prognosis, and survival of cancer patients, as well as those infected by pathogens or suffering from immune deficiencies.
Career Highlights
Throughout his career, Paul Borron has demonstrated a commitment to advancing medical science. His innovative approaches have the potential to transform treatment protocols for patients with various health challenges. His work is characterized by a strong focus on practical applications that can lead to improved patient outcomes.
Collaborations
Paul Borron collaborates with Constance Neely Wilson, contributing to the development of groundbreaking technologies in the field of immunology. Their partnership exemplifies the importance of teamwork in driving innovation and achieving significant advancements in medical research.
Conclusion
Paul Borron's contributions to the field of antigenic response technologies highlight his role as a key innovator in immunology. His patent and collaborative efforts pave the way for improved treatments and diagnostic methods, ultimately benefiting patients worldwide.